当前位置:首页 - 行情中心 - 奥翔药业(603229) - 财务分析

奥翔药业

(603229)

  

流通市值:51.98亿  总市值:51.98亿
流通股本:8.30亿   总股本:8.30亿

奥翔药业(603229)财务分析

利润表
报告期2026-09-302026-06-302026-03-312025-12-31
营业总收入610,255,079.48467,614,591.81308,673,252.77792,759,011.85
营业总成本546,945,101.54361,464,471.53193,930,900.75670,523,160.48
其他经营收益
营业利润71,579,689.79130,363,944.28107,365,877.18140,045,154.4
利润总额71,934,346.12130,294,602.53107,330,659.49137,903,857.48
净利润71,931,283.14119,840,785.4296,662,497.25130,570,123.6
每股收益
其他综合收益-392,450.69-263,400.55199,836.82-262,560.71
综合收益总额71,538,832.45119,577,384.8796,862,334.07130,307,562.89
资产负债表
报告期2026-09-302026-06-302026-03-312025-12-31
流动资产:
流动资产合计1,631,225,124.091,780,599,715.81,878,870,467.461,815,331,179.77
非流动资产:
非流动资产合计1,253,107,457.451,296,804,735.931,277,968,052.61,269,919,485.68
资产总计2,884,332,581.543,077,404,451.733,156,838,520.063,085,250,665.45
流动负债:
流动负债合计533,339,644.43602,037,780.71711,085,662.81736,019,871.51
非流动负债:
非流动负债合计62,902,031.5186,431,072.5278,566,579.2779,872,580.31
负债合计596,241,675.94688,468,853.23789,652,242.08815,892,451.82
所有者权益(或股东权益):
归属于母公司股东权益合计2,288,090,905.62,388,935,598.52,367,186,277.982,269,358,213.63
股东权益合计2,288,090,905.62,388,935,598.52,367,186,277.982,269,358,213.63
负债和股东权益合计2,884,332,581.543,077,404,451.733,156,838,520.063,085,250,665.45
现金流量表
报告期2026-09-302026-06-302026-03-312025-12-31
经营活动产生的现金流量:
经营活动现金流入小计603,740,912.09349,505,476.86188,380,264.34984,246,886.73
经营活动现金流出小计547,370,424.82391,868,729.45222,415,242.33827,737,972.48
经营活动产生的现金流量净额56,370,487.27-42,363,252.59-34,034,977.99156,508,914.25
投资活动产生的现金流量:
投资活动现金流入小计19,801,399.8929,446,426.648,887,293.0867,034,020.97
投资活动现金流出小计89,744,193.8954,423,232.730,180,011.68125,457,198.33
投资活动产生的现金流量净额-69,942,794-24,976,806.06-21,292,718.6-58,423,177.36
筹资活动产生的现金流量:
筹资活动现金流入小计255,012,627.94216,375,895.24101,602,116.48524,517,726.44
筹资活动现金流出小计456,259,129.94331,314,383.5893,972,034.93474,066,371.82
筹资活动产生的现金流量净额-201,246,502-114,938,488.347,630,081.5550,451,354.62
汇率变动对现金及现金等价物的影响-51,508,010.28-33,254,046.82-22,048,408.04-17,457,141.89
现金及现金等价物净增加额-266,326,819.01-215,532,593.81-69,746,023.08131,079,949.62
期末现金及现金等价物余额913,334,349.76964,128,574.961,109,915,145.691,179,661,168.77
补充资料:
现金及现金等价物的净增加额--215,532,593.81-131,079,949.62
TOP↑